Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles F Craddock

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Hematology. American Society of Hematology. Education Program|December 4, 2018
We do still transplant CML, don't we?Charles F Craddock
Ejhaem|September 2, 2022
Heterogeneous genetic and non-genetic mechanisms contribute to response and resistance to azacitidine monotherapyVasiliki Symeonidou, Marlen Metzner, Batchimeg Usukhbayar, et al.
Haematologica|July 2, 2013
Subsequent donation requests among 2472 unrelated hematopoietic progenitor cell donors are associated with bone marrow harvestRobert N Lown, Sameer Tulpule, Nigel H Russell, et al.
Cancer Research|August 17, 2002
The T-lineage-affiliated CD2 gene lies within an open chromatin environment in acute promyelocytic leukemia cellsDavid Grimwade, Susan V Outram, Rajinder Flora, et al.
Blood|September 25, 2003
The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemiaMark A Cook, Donald W Milligan, Christopher D Fegan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemiaAlan K Burnett, Nigel H Russell, Robert K Hills, et al.
Blood|October 10, 2015
Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation eventDavid M Burns, Rose Tierney, Claire Shannon-Lowe, et al.
Blood|September 21, 2007
Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemiaEduardo Olavarria, Shamyla Siddique, Michael J Griffiths, et al.
Blood|January 12, 2012
Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)Oliver C Goodyear, Mike Dennis, Nadira Y Jilani, et al.
Haematologica|December 21, 2014
Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemiaEolia Brissot, Myriam Labopin, Marielle M Beckers, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Hematology. American Society of Hematology. Education Program|December 4, 2018
We do still transplant CML, don't we?Charles F Craddock
Ejhaem|September 2, 2022
Heterogeneous genetic and non-genetic mechanisms contribute to response and resistance to azacitidine monotherapyVasiliki Symeonidou, Marlen Metzner, Batchimeg Usukhbayar, et al.
Haematologica|July 2, 2013
Subsequent donation requests among 2472 unrelated hematopoietic progenitor cell donors are associated with bone marrow harvestRobert N Lown, Sameer Tulpule, Nigel H Russell, et al.
Cancer Research|August 17, 2002
The T-lineage-affiliated CD2 gene lies within an open chromatin environment in acute promyelocytic leukemia cellsDavid Grimwade, Susan V Outram, Rajinder Flora, et al.
Blood|September 25, 2003
The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemiaMark A Cook, Donald W Milligan, Christopher D Fegan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemiaAlan K Burnett, Nigel H Russell, Robert K Hills, et al.
Blood|October 10, 2015
Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation eventDavid M Burns, Rose Tierney, Claire Shannon-Lowe, et al.
Blood|September 21, 2007
Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemiaEduardo Olavarria, Shamyla Siddique, Michael J Griffiths, et al.
Blood|January 12, 2012
Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)Oliver C Goodyear, Mike Dennis, Nadira Y Jilani, et al.
Haematologica|December 21, 2014
Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemiaEolia Brissot, Myriam Labopin, Marielle M Beckers, et al.
Pageof 2